Metformin Ziso Madonhwe eKurapwa kweMacular Degeneration

A BATA FreeRelease | eTurboNews | eTN
Avatar of Linda Hohnholz
rakanyorwa Linda Hohnholz

Curative Biotechnology, Inc. yakazivisa nhasi kuti kambani yafambira mberi mune yayo Yakanaka Laboratory Practice (GLP) toxicology kudzidza.

Chidzidzo chazvino chakagadzirirwa kuyera kushivirira, pharmacokinetics uye chero yemuno kana systemic toxicity ye reformulated metformin kana ichinge yakapihwa ne topical ocular delivery. Chidzidzo ichi chinoongororawo kugovera kwenyama yemaziso.

Iyo Yakanaka Laboratory Practice (GLP) toxicology kudzidza chinhu chinodiwa kune FDA Investigational New Drug (IND) faira.

Kushivirira kwemaziso kunosanganisira kucherechedzwa pakuita dosing, kuongororwa kwekiriniki kaviri pazuva (kuongororwa kwemaitiro / zviratidzo zvekiriniki zvakanyanya kutariswa kumaziso), kuongororwa kwemaziso neBoard-yakasimbiswa veterinary ophthalmologist maererano neyakagadziridzwa Hackett-McDonald scoring scale, uye ocular histopathology. .

Pasi peChibvumirano cheCooperative Research and Development Agreement (CRADA), National Eye Institute (NEI) uye Curative Biotechnology, Inc. ichabatana kuongorora Curative's proprietary ocular metformin kuumbwa muzvidzidzo zvekiriniki kurapwa kwepakati uye kunonoka-nhanho Age-Inoenderana Macular Degeneration. (AMD) chirwere.

Nezvomunyori

Avatar of Linda Hohnholz

Linda Hohnholz

Editor mukuru we eTurboNews yakavakirwa muTN HQ.

Subscribe
Notify of
muenzi
0 Comments
Inline feedbacks
Ona zvese zvataurwa
0
Ndingade pfungwa dzako, ndapota taura.x
Govera ku...